[Phenotypic analysis in peripheral blood lymphocytes of patients with pulmonary tuberculosis]

N Shijubo1, F Nakanishi, M Hirasawa

  • 1Department of Internal Medicine, Sapporo Medical College, Japan.

Kekkaku : [Tuberculosis]
|September 1, 1992
PubMed

Insights

Peripheral blood analysis in tuberculosis reveals a significant decrease in CD8 positive T cells and a tendency for higher CD4 positive T cells. Previous chemotherapy impacts T cell subsets, influencing immune responses in pulmonary tuberculosis patients.

Area of Science:

  • Immunology
  • Hematology
  • Infectious Diseases

Context:

  • Tuberculosis (TB) remains a global health challenge, necessitating a deeper understanding of its immunological underpinnings.
  • Peripheral blood lymphocyte phenotypes offer insights into immune system alterations during active disease.

Purpose:

  • To investigate the immunological profile of peripheral blood lymphocytes in patients with pulmonary tuberculosis.
  • To compare lymphocyte subsets between tuberculosis patients and healthy controls.
  • To evaluate the influence of prior chemotherapy on lymphocyte phenotypes in TB patients.

Summary:

  • Analysis of 96 pulmonary tuberculosis patients and 43 controls showed significantly decreased CD8+ T cells in TB patients.
  • While CD3, CD4, CD19, CD16, and gamma delta T cell receptor (TCR) expression showed no significant difference, CD4+ T cells tended to be higher in TB patients.
  • Previous chemotherapy was associated with higher CD4+, lower CD8+, and lower gamma delta TCR+ cells. Specific TB types and expansion stages showed variations in CD4+, CD8+, and CD19+ cells post-chemotherapy.

Impact:

  • Characterizes the distinct peripheral blood lymphocyte phenotype in pulmonary tuberculosis, marked by CD4+ T cell predominance and CD8+ T cell reduction.
  • Highlights the modulatory effect of prior chemotherapy on immune cell populations in tuberculosis.
  • Provides a basis for further research into immune-based diagnostics and therapeutic strategies for tuberculosis.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...